B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

) and newly appreciated age-associated B cells (ABCs), a distinct subset that accumulates with aging and potentially exacerbates atherosclerosis. By integrating insights from preclinical models and human studies, we describe the mechanisms through which B cell subsets influence ASCVD, including antigen presentation and immune checkpoint-mediated communication, secretion of cytokines and chemokines, and we highlight that humoral immunity in atherosclerosis reflects a context-dependent interplay between antibody effector properties and antigenic targets rather than antibody class alone. Finally, we explore how the advances in our understanding of B cells may guide the development of more targeted immunomodulatory therapies that enhance atheroprotective B cell functions while limiting atherogenic responses.

Authors

Institutions

Publication Details

Journal
Immunological Reviews
Published
2026-04-24
DOI
https://doi.org/10.1111/imr.70124
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

Amanda C. Foks, Sophieke Lems, Coleen A. McNamara, Megan Grace Mazzei
Immunological Reviews
Atherosclerosis and Cardiovascular Diseases
article

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

Amanda C. Foks, Sophieke Lems, Coleen A. McNamara, Megan Grace Mazzei
article en

Abstract

) and newly appreciated age-associated B cells (ABCs), a distinct subset that accumulates with aging and potentially exacerbates atherosclerosis. By integrating insights from preclinical models and human studies, we describe the mechanisms through which B cell subsets influence ASCVD, including antigen presentation and immune checkpoint-mediated communication, secretion of cytokines and chemokines, and we highlight that humoral immunity in atherosclerosis reflects a context-dependent interplay between antibody effector properties and antigenic targets rather than antibody class alone. Finally, we explore how the advances in our understanding of B cells may guide the development of more targeted immunomodulatory therapies that enhance atheroprotective B cell functions while limiting atherogenic responses.

Immunological ReviewsVol. 339(1)
Carter Center (US), Centre for Human Drug Research (NL), University of Virginia (US)
Fondation Leducq, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, HORIZON EUROPE European Innovation Council
Good health and well-being
Openalex Percentile: Top 7%
Atherosclerosis and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts — Amanda C. Foks, Sophieke Lems, et al. · Immunological Reviews (2026) | TGRS Research Map | TGRS